Physician

Matthew J Campbell, M.D.

According to 2025 Medicare claims, Matthew Campbell, M.D. (NPI: 1043284367) practices family practice in the Niles, MI market, with the plurality of this provider's patient population coming from Berrien, MI. This provider's primary affiliated billing organization is MATTHEW CAMPBELL, MD, PLC (NPI: 1477711315; TIN: 753062476) and primary practice location at 49085-2178. Campbell is affiliated with the West Michigan Accountable Care Organization, LLC (ACO ID: A4626), participating under the MSSP model.

Campbell's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 362 traditional Medicare patients, billed 2,889 HCPCS/CPT codes, and received $149,738 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 8,865 prescription claims across 660 beneficiaries totaling $812,436 in drug costs, led by Ozempic (Semaglutide). DME data shows 28 claims. Open Payments data shows 1 records totaling $13. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $122,462 and ending at $149,738. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $312,667 to $812,436. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $11,116 and ending at $10,058.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	309	1,892	$122,462
2016	326	1,875	$118,124
2017	324	1,921	$117,394
2018	337	1,923	$120,313
2019	366	1,940	$130,108
2020	348	1,530	$110,754
2021	375	1,783	$152,272
2022	369	1,735	$64,756
2023	343	1,857	$73,478
2024	362	2,889	$149,738

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	359	4,903	$312,667
2016	390	5,551	$336,540
2017	400	5,815	$329,925
2018	436	6,133	$340,353
2019	472	6,292	$340,364
2020	488	6,555	$379,345
2021	534	6,918	$415,942
2022	594	7,383	$495,347
2023	597	8,011	$746,201
2024	660	8,865	$812,436

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	24	165	$7,329
2016	38	107	$2,058
2017	21	173	$5,925
2018	24	323	$10,568
2019	19	256	$6,634
2020	19	117	$3,104
2021	24	126	$2,912
2022	34	134	$6,192
2023	37	131	$6,410
2024	13	28	$451

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	254	254	$122
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	331	910	$79
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	88	113	$57
G0444	Annual depression screening, 5 to 15 minutes	252	252	$17
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	333	893	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	148	5,046	$145,426
Mounjaro	Tirzepatide	123	3,956	$140,766
Jardiance	Empagliflozin	66	3,380	$65,439
Trulicity	Dulaglutide	36	1,512	$50,094
Invokana	Canagliflozin	36	2,280	$41,116

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	13	28	$451

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$13	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Matthew J. Campbell, M.D.?

Tedicare shows public-source Medicare data for Matthew J. Campbell, M.D. (NPI 1043284367), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew J. Campbell, M.D. have ACO affiliation data?

Matthew J. Campbell, M.D. is shown with ACO affiliation data for West Michigan Accountable Care Organization, LLC (MSSP, ACO ID A4626).

What billing organization is linked to Matthew J. Campbell, M.D.?

Matthew J. Campbell, M.D. is linked to MATTHEW CAMPBELL, MD, PLC (billing NPI 1477711315) in the available physician profile data.

Does Matthew J. Campbell, M.D. have Open Payments data?

Matthew J. Campbell, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.